Leaflet IFFEZA 50mcg / 5mcg pressurised inhalation suspension

Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: inhalation

Substance: fluticasone + formoterol (glucocorticoid + beta-2 adrenergic agonist)

ATC: R03AK07 (Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

The combination of fluticasone and formoterol is used to treat asthma and chronic obstructive pulmonary disease (COPD). Fluticasone is a corticosteroid that reduces airway inflammation, while formoterol is a bronchodilator that relaxes the bronchial muscles, making breathing easier. Together, these substances help prevent asthma attacks and relieve respiratory symptoms.

The medication is administered by inhalation, usually twice a day, as directed by your doctor. It is important to use the inhaler regularly, even if you have no symptoms, to maintain disease control. Do not use this medication for quick relief of acute attacks.

Side effects may include throat irritation, hoarseness, oral infections, or palpitations. Rarely, severe allergic reactions or worsening of respiratory symptoms may occur. If you experience difficulty breathing or facial swelling, seek medical help immediately.

The combination of fluticasone and formoterol is effective in managing asthma and COPD, but correct use and medical monitoring are necessary to prevent complications and ensure treatment effectiveness.

General data about IFFEZA 50mcg / 5mcg

  • Substance: fluticasone + formoterol
  • Date of latest medicines list: 02-10-2013
  • Product code: W59660001
  • Concentration: 50mcg / 5mcg
  • Pharmaceutical form: pressurised inhalation suspension
  • Quantity: 1
  • Product type: Original
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Concentrations available for fluticasone + formoterol

  • 125mcg/5mcg
  • 250mcg/10mcg
  • 50mcg/5mcg